173 related articles for article (PubMed ID: 20201819)
1. The nociceptin/orphanin FQ system as a target for treating alcoholism.
Murphy NP
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):87-93. PubMed ID: 20201819
[TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
3. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice.
Ploj K; Roman E; Gustavsson L; Nylander I
Brain Res Bull; 2000 Sep; 53(2):219-26. PubMed ID: 11044599
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain.
Clarke S; Chen Z; Hsu MS; Hill RG; Pintar JE; Kitchen I
Neuroscience; 2003; 117(1):157-68. PubMed ID: 12605902
[TBL] [Abstract][Full Text] [Related]
5. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
Sakoori K; Murphy NP
Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627
[TBL] [Abstract][Full Text] [Related]
6. The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats.
Ciccocioppo R; Economidou D; Fedeli A; Massi M
Physiol Behav; 2003 Jun; 79(1):121-8. PubMed ID: 12818717
[TBL] [Abstract][Full Text] [Related]
7. The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.
Aziz AM; Brothers S; Sartor G; Holm L; Heilig M; Wahlestedt C; Thorsell A
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3553-63. PubMed ID: 27515665
[TBL] [Abstract][Full Text] [Related]
8. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
9. Prenatal ethanol induces an anxiety phenotype and alters expression of dynorphin & nociceptin/orphanin FQ genes.
Wille-Bille A; Miranda-Morales RS; Pucci M; Bellia F; D'Addario C; Pautassi RM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():77-88. PubMed ID: 29678771
[TBL] [Abstract][Full Text] [Related]
10. Nociceptin/orphanin-FQ modulation of learning and memory.
Abdel-Mouttalib O
Vitam Horm; 2015; 97():323-45. PubMed ID: 25677778
[TBL] [Abstract][Full Text] [Related]
11. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
Zaveri NT
Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
[TBL] [Abstract][Full Text] [Related]
12. Nociceptin / orphanin FQ (NOP) receptors as novel potential target in the treatment of gastrointestinal diseases.
Sobczak M; Sałaga M; Storr M; Fichna J
Curr Drug Targets; 2013 Sep; 14(10):1203-9. PubMed ID: 23773151
[TBL] [Abstract][Full Text] [Related]
13. Nociceptin Receptors in Alcohol Use Disorders: A Positron Emission Tomography Study Using [
Narendran R; Ciccocioppo R; Lopresti B; Paris J; Himes ML; Mason NS
Biol Psychiatry; 2018 Nov; 84(10):708-714. PubMed ID: 28711193
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: integrated drug-design and structure-activity relationships for orally potent, metabolically stable and potential-risk reduced novel non-peptide nociceptin/orphanin FQ receptor agonist as antianxiety drug.
Hayashi S; Hirao A; Nakamura H; Yamamura K; Mizuno K; Yamashita H
Chem Biol Drug Des; 2009 Oct; 74(4):369-81. PubMed ID: 19691471
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin and the nociceptin receptor in learning and memory.
Andero R
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():45-50. PubMed ID: 25724763
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder.
Zhang Y; Simpson-Durand CD; Standifer KM
Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin/orphanin FQ and drugs of abuse.
Ciccocioppo R; Angeletti S; Panocka I; Massi M
Peptides; 2000 Jul; 21(7):1071-80. PubMed ID: 10998542
[TBL] [Abstract][Full Text] [Related]
20. The neuronal circuit between nociceptin/orphanin FQ and hypocretins/orexins coordinately modulates stress-induced analgesia and anxiety-related behavior.
Xie XS
Vitam Horm; 2015; 97():295-321. PubMed ID: 25677777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
